Table 4 Spearman rank correlations between demographic and clinical factors and soy consumption (N = 100)
From: Prevalence, sources, and predictors of soy consumption in breast cancer
Predictors | Soy consumption (yes versus no) | Weekly gram weight of soy | Weekly milligrams of Genistein | Weekly milligrams of Daidzein |
|---|---|---|---|---|
Age at Diagnosis | 0.014 | 0.06 | 0.12 | 0.12 |
BMI | -0.04 | -0.11 | -0.11 | -0.11 |
Ethnicity | -0.23* | 0.18 | 0.13 | 0.13 |
Stage at Diagnosis | -0.18 | -0.25* | -0.25* | -0.24* |
Prior Treatment History | -0.12 | -0.19 | -0.18 | -0.18 |
Menstrual Status | 0.07 | 0.11 | 0.14 | 0.14 |
Estrogen/Progesterone Receptor Status | 0.16 | 0.08 | 0.07 | 0.07 |
Tamoxifen Use | -0.21* | -0.20 | -0.16 | -0.16 |